Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients
NCT00758134
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class
Stopped
Insufficient accrual
Conditions
NON-SMALL CELL LUNG CANCER
Interventions
DRUG:
Trastuzumab (Herceptin)
Sponsor
Armando Santoro, MD